These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 750185)

  • 1. Interruption of early first trimester pregnancy by single vaginal administration of 15-methyl-pgf2 alpha-methyl ester.
    Gréen K; Bygdeman M; Bremme K
    Contraception; 1978 Dec; 18(6):551-60. PubMed ID: 750185
    [No Abstract]   [Full Text] [Related]  

  • 2. On the mechanism of action of 15-methyl-PGF2 alpha as an abortifacient.
    Gréen K; Svanborg K
    Prostaglandins; 1979 Feb; 17(2):277-82. PubMed ID: 441436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early pregnancy interruption with a single PGF2 alpha 15-methyl-analogue vaginal suppository.
    Borten M; Friedman EA
    J Reprod Med; 1985 Oct; 30(10):741-4. PubMed ID: 3877806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinical study on the interruption of first and second trimester pregnancies by vaginal suppositories of dl-15 methyl PGF2 alpha methyl ester].
    Fan GS; Xu YD; Wu YM; Hu CH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Feb; 9(1):65-8. PubMed ID: 2954692
    [No Abstract]   [Full Text] [Related]  

  • 5. Pregnancy-specific beta-1-glycoprotein and chorionic gonadotropin levels after first-trimester abortions.
    Mandelin M; Rutanen EM; Heikinheimo M; Jalanko H; Seppälä M
    Obstet Gynecol; 1978 Sep; 52(3):314-7. PubMed ID: 81473
    [No Abstract]   [Full Text] [Related]  

  • 6. [Development of a long-acting vaginal suppository for termination of 2d trimester pregnancy and for preoperative cervical dilatation].
    Bygdeman M; Gréen K; Lundström V
    Lakartidningen; 1977 Nov; 74(46):4107-9. PubMed ID: 926943
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of second trimester abortion: comparison between vaginal 15-methyl-PGF2alpha methyl ester and intra-amniotic PGF2alpha.
    Mandelin M; Kajanoja P
    Prostaglandins; 1978 Dec; 16(6):995-1001. PubMed ID: 748987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical priming prior to first-trimester suction abortion with a single 15-methyl-prostaglandin F2 alpha vaginal suppository.
    Lauersen NH; Seidman S; Wilson KH
    Am J Obstet Gynecol; 1979 Dec; 135(8):1116-8. PubMed ID: 391045
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of 15-methyl PGF2-alpha for termination of early pregnancy].
    Manuilova IA; Murashko LE; Fanchenko ND; Kolod'ko VG
    Sov Med; 1980; (3):49-53. PubMed ID: 7376012
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of abortion by vaginal administration of 15(s)15-methyl prostaglandin F2alpha methyl ester. A comparison of two delivery systems.
    Bygdeman M; Gréen K; Lundström V; Ramadan M; Fotiou S; Bergström S
    Prostaglandins; 1976; 12 Suppl():27-51. PubMed ID: 968064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
    Puri CP; Laumas V; Agarwal N; Zoremthangi ; Hingorani V; Laumas KR
    Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of a long-acting vaginal suppository of 15-ME-PGF2 alpha in first and second trimester abortion.
    Lauersen NH; Wilson KH
    Adv Prostaglandin Thromboxane Res; 1980; 8():1435-41. PubMed ID: 7376994
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of a study of menses induction using a vaginal suppository containing 3.0 mg 15(S)-15-methyl-PGF2 alpha methyl ester.
    Spilman CH; Gutknecht GD; Beuving DC; Southern EM
    Contraception; 1980 Apr; 21(4):535-63. PubMed ID: 6248291
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of two prostaglandins used to terminate midtrimester pregnancy.
    Gookin KS; White CK; Whitworth NS; Wiser WL; Morrison JC
    South Med J; 1984 Jun; 77(6):717-8, 721. PubMed ID: 6587588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a single dose schedule of 15 (S) 15 methyl PGF2 alpha methyl ester suppository for the termination of 10-14 weeks of pregnancy.
    Kinra G; Agarwal N; Jagannath KT; Hingorani V
    Contraception; 1978 May; 17(5):455-64. PubMed ID: 657810
    [No Abstract]   [Full Text] [Related]  

  • 16. Early pregnancy interruption with two 15-ME-PGF2a suppositories.
    Lauersen NH; Wilson KH
    Contraception; 1980 Mar; 21(3):273-82. PubMed ID: 7389352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 15 (S) 15 methyl-PGF 2 alpha methyl ester suppositories with a two dose schedule for termination of early pregnancy.
    Zoremthangi B; Agarwal N; Puri CP; Laumas KR; Hingorani V
    Contraception; 1976 Nov; 14(5):519-27. PubMed ID: 975834
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma levels of 15 (S) 15-methyl-PGF 2 alpha-methyl ester following vaginal administration for induction of abortion in women.
    Bhaskar A; Dimov V; Baliga S; Kinra G; Hingorani V; Laumas KR
    Contraception; 1979 Nov; 20(5):519-31. PubMed ID: 527343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early pregnancy interruption by 15 (S) 15 methyl prostaglandin F2alpha methyl ester.
    Bygdeman M; Martin JN; Leader A; Lundström V; Ramadan M; Eneroth P; Gréen K
    Obstet Gynecol; 1976 Aug; 48(2):221-4. PubMed ID: 940655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of prostaglandins for abortion.
    Lauersen NH
    Acta Obstet Gynecol Scand Suppl; 1979; 81():1-36. PubMed ID: 377889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.